Muntingia calabura Leaves Extracts to Ameliorate chronic obstruction pulmonary diseases by Inhibiting IL-17a Signaling: In silico and in vivo studies

Keyphrases

• Affinity Values 33%
• Anti-inflammatory Potential 33%
• Antioxidant 33%
• Antioxidant Potential 33%
• Binding Affinity 66%
• Bioinformatics Study 33%
• Cause of Death 33%
• Chronic Obstructive Pulmonary Disease 100%
• Cigarette Smoking 33%
• Continuous Exposure 33%
• Evergreen 33%
• Fast-growing Plants 33%
• IL-17 Signaling Pathway 33%
• In Silico 100%
• Inflammation Response 33%
• Inhalants 33%
• Interleukin-17 (IL-17) 100%
• Kersen 100%
• Kersen Leaves 100%
• Leaf Extract 100%
• Lipopolysaccharide 33%
• Lower Respiratory 33%
• Lung 33%
• Macromolecules 66%
• Mechanism of Action 33%
• Molecular Analysis 33%
• Molecular Docking 33%
• Mouse Model 66%
• Mucus Production 33%
• Muntingia Calabura 100%
• Natural Compounds 33%
• Oxidative Stress 33%
• Pharmacological Therapy 33%
• Quercetin 100%
• Quercitrin 33%
• Respiratory System 33%
• Stress Accumulation 33%
• Stress Cascade 33%
• Therapeutic Candidates 33%
• Therapeutic Potential 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anti-Inflammatory Drug 18%
• Antioxidant 18%
• Chronic Obstructive Lung Disease 100%
• Cigarette Smoke 9%
• Cytokine 9%
• Diseases 18%
• Inflammation 9%
• Interleukin 17 9%
• Lipopolysaccharide 9%
• Lung Disease 100%
• Mouse Model 18%
• Natural Product 9%
• Obstruction 100%
• Pharmacotherapy 9%
• Quercetin 27%
• Quercitrin 9%
• Tumor Necrosis Factor 18%